A new device was able to distinguish between mild and very severe chronic obstructive pulmonary disease (COPD).

A COPD treatment for former smokers developed by Regeneron Pharmaceuticals and Sanofi failed to meet its primary endpoint in ...

Results released Friday show itepekimab succeeded in one Phase 3 trial but failed in a second, sinking shares of both partner ...

An experimental COPD drug from Sanofi and Regeneron showed mixed results in a pair of studies, sending the companies' shares ...

Connected drug delivery devices integrate digital connectivity — often via Bluetooth — with traditional drug administration ...

The smart inhalers market is experiencing significant growth, driven by the increasing incidence of respiratory diseases like asthma and COPD, techno ...

Gait parameters in people with COPD progressively worsen with disease severity and differ significantly from healthy older ...

For users requiring stationary oxygen therapy, VARON's Serene 5 and VH-2 PRO models offer dependable medical-grade oxygen concentration ideal for home use. With intuitive controls, energy efficiency, ...

When Lily MacDonald first signed in to an online workout session for women with COPD, she was sure she wasn't going to like ...

MUSC Health Florence Medical Center has spearheaded the introduction of an advanced aerosol delivery system – one that is now transforming how respiratory patients receive breathing treatments in ...

The respiratory inhaler devices market is a critical component of the global healthcare industry, focusing on devices designed to deliver medication directly to the lungs to treat respiratory diseases ...

Request To Download Free Sample of This Strategic Report @ What is Saudi Arabia Lung Stents Market ? The Saudi Arabian Lung Stents Market is a critical and evolving sector deeply connected to ...